1887

Abstract

Antimicrobial susceptibility is slow to determine, taking several days to fully impact treatment. This proof-of-concept study assessed the feasibility of using machine-learning techniques for analysis of data produced by the flow cytometer-assisted antimicrobial susceptibility test (FAST) method we developed.

We used machine learning to assess the effect of antimicrobial agents on bacteria, comparing FAST results with broth microdilution (BMD) antimicrobial susceptibility tests (ASTs). We used (1), (1) and (2) strains to develop the machine-learning algorithm, an expanded panel including these plus (2), (3), (1), (1), (2) and (1), tested against FAST and BMD (Sensititre, Oxoid), then two representative isolates directly from blood cultures.

Our data machines defined an antibiotic-unexposed population (AUP) of bacteria, classified the FAST result by antimicrobial concentration range, and determined a concentration-dependent antimicrobial effect (CDE) to establish a predicted inhibitory concentration (PIC). Reference strains of and tested with different antimicrobial agents demonstrated concordance between BMD results and machine-learning analysis (CA, categoric agreement of 91 %; EA, essential agreement of 100 %). CA was achieved in 35 (83 %) and EA in 28 (67 %) by machine learning on first pass in a challenge panel of 27 Gram-negative and 15 Gram-positive ASTs. Same-day AST results were obtained from clinical (1) and (1) isolates.

The combination of machine learning with the FAST method generated same-day AST results and has the potential to aid early antimicrobial treatment decisions, stewardship and detection of resistance.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial License.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001092
2019-10-30
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/69/5/657.html?itemId=/content/journal/jmm/10.1099/jmm.0.001092&mimeType=html&fmt=ahah

References

  1. International Standards Organisation 2006; ISO 20776-1:2006. Clinical laboratory testing and in vitro diagnostic test systems – Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices – Part 1: Reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases. https://www.iso.org/standard/41630.html
  2. Inglis TJJ, Urosevic N. Where sepsis and antimicrobial resistance countermeasures converge. Front Public Health 2017; 5:6 [View Article][PubMed]
    [Google Scholar]
  3. HM Government Rapid Diagnostics: Stopping Unnecessary Use of Antibiotics Westminster, UK: The Review on Antimicrobial Resistance; 2015
    [Google Scholar]
  4. Mulroney KT, Hall JM, Huang X, Turnbull E, Bzdyl NM et al. Rapid susceptibility profiling of carbapenem-resistant Klebsiella pneumoniae . Sci Rep 2017; 7:1903 [View Article][PubMed]
    [Google Scholar]
  5. Inglis TJJ. Editorial conference report 5th international one health congress, saskatoon, Canada, 22–25 June 2018. J Med Microbiol 2018; 67:1665–1666 [View Article][PubMed]
    [Google Scholar]
  6. Steen HB, Boye E, Skarstad K, Bloom B, Godal T et al. Applications of flow cytometry on bacteria: cell cycle kinetics, drug effects, and quantitation of antibody binding. Cytometry 1982; 2:249–257 [View Article][PubMed]
    [Google Scholar]
  7. Boye E, Steen HB, Skarstad K. Flow cytometry of bacteria: a promising tool in experimental and clinical microbiology. Microbiology 1983; 129:973–980 [View Article]
    [Google Scholar]
  8. Gant VA, Warnes G, Phillips I, Savidge GF. The application of flow cytometry to the study of bacterial responses to antibiotics. J Med Microbiol 1993; 39:147–154 [View Article][PubMed]
    [Google Scholar]
  9. Demšar J, Curk T, Erjavek A, Gorup C, Hocevar T et al. Orange: data mining toolbox in python. J Machine Learning Res 2013; 14:2349–2353
    [Google Scholar]
  10. Spidlen J, Moore W, Parks D, Goldberg M, Bray C et al. Data file standard for flow cytometry, version FCS 3.1. Cytometry A 2010; 77:97–100 [View Article][PubMed]
    [Google Scholar]
  11. Andrews JM, Howe RA. BSAC Working Party on Susceptibility Testing BSAC standardized disc susceptibility testing method (version 10). J Antimicrob Chemother 2011; 66:2726–2757
    [Google Scholar]
  12. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34:1589–1596 [View Article][PubMed]
    [Google Scholar]
  13. Pruinelli L, Westra BL, Yadav P, Hoff A, Steinbach M et al. Delay within the 3-hour surviving sepsis campaign guideline on mortality for patients with severe sepsis and septic shock. Crit Care Med 2018; 46:500–505 [View Article][PubMed]
    [Google Scholar]
  14. Shapiro HM. Multiparameter flow cytometry of bacteria: implications for diagnostics and therapeutics. Cytometry 2001; 43:223–226 [View Article][PubMed]
    [Google Scholar]
  15. Nodari CS, Ribeiro VB, Barth AL. Imipenem heteroresistance: high prevalence among Enterobacteriaceae Klebsiella pneumoniae carbapenemase producers. J Med Microbiol 2015; 64:124–126 [View Article][PubMed]
    [Google Scholar]
  16. Bardet L, Baron S, Leangapichart T, Okdah L, Diene SM et al. Deciphering heteroresistance to colistin in a Klebsiella pneumoniae isolate from Marseille, France. Antimicrob Agents Chemother 2017; 61:pii: e00356-17 [View Article]
    [Google Scholar]
  17. Osthoff M, Siegemund M, Balestra G, Abdul-Aziz MH, Roberts JA. Prolonged administration of β-lactam antibiotics - a comprehensive review and critical appraisal. Swiss Med Wkly 2016; 146:w14368 [View Article][PubMed]
    [Google Scholar]
  18. Pagkalis S, Mantadakis E, Mavros MN, Ammari C, Falagas ME. Pharmacological considerations for the proper clinical use of aminoglycosides. Drugs 2011; 71:2277–2294 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001092
Loading
/content/journal/jmm/10.1099/jmm.0.001092
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error